Desk› Healthcare› Aarti Pharmalabs Ltd

Aarti Pharmalabs Ltd

BSE 543748 AARTIPHARM INE0LRU01027

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

16 filings · 7 material · busiest 2026-08-07

What it files

Analyst / Investor Meet2 Change in Directorate2 Newspaper Publication1 Concall Transcript1 Record Date1 Investor Presentation1 Board Outcome1 Results1

Filings

16 in the window

18 August 2026

Newspaper Publication

Newspaper Publication

Please find enclosed

Company Update / Newspaper Publication View filing →
17 August 2026

Concall Transcript

Earnings Call Transcript

Q1 FY 27 Earnings Call Transcript

Company Update / Earnings Call Transcript View filing →
17 August 2026

Record Date

Record Date For Dividend For FY 2025-26

Disclosure as enclosed

Corp. Action / Record Date View filing →
10 August 2026

Investor Presentation

Investor Presentation

Q1 FY 2027 Investor Presentation

Company Update / Investor Presentation View filing →
10 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio Recording of Conference Call for Investor and Analysts

Company Update / Analyst / Investor Meet View filing →
7 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026.

Outcome of Board Meeting held on August 07, 2026.

Board Meeting / Outcome of Board Meeting View filing →
7 August 2026

Results

Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30, 2026

Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter Ended June 30, 2026

Result / Financial Results View filing →
7 August 2026

Change in Directorate

Change in Directorate

Disclosure as enclosed

Company Update / Change in Directorate View filing →
7 August 2026

General

Approved Capacity Addition For Development Of Intermediate Block

Disclosure as enclosed

Company Update / General View filing →
7 August 2026

Change in Directorate

Change in Directorate

As enclosed

Company Update / Change in Directorate View filing →
3 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Monday, August 10, 2026, at 4:00 p.m. (IST) to discuss the Company's Q1-FY27 Financial ....

Company Update / Analyst / Investor Meet View filing →
28 July 2026

Board Meeting

Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.

Aarti Pharmalabs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the unaudited financial results ....

Board Meeting / Board Meeting View filing →
7 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
30 June 2026

Press Release

Press Release / Media Release

Please find enclosed

Company Update / Press Release / Media Release View filing →
24 June 2026

Trading Window

Closure of Trading Window

Intimation of Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →
24 June 2026

ESOP Allotment

Allotment of ESOP / ESPS

Please find enclosed

Company Update / Allotment of ESOP / ESPS View filing →